Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

In 2025, the AI landscape is undergoing a transformative shift, expanding into two critical new layers: the application layer ...

Markets are panicking as AI stocks sell off due to DeepSeek's cost-effective advancements, but this is bullish for long-term ...